1. The NSS-2 Bridge is a nerve stimulation device to treat opioid withdrawal symptoms, such as nausea, vomiting and abdominal pain.
2. Mepsevii is an enzyme replacement therapy for patients with Mucopolysaccharidosis VII, an inherited metabolic condition.
3. Hemlibra is a once-weekly injection for patients with hemophilia A who have developed a resistance to other treatments.
4. Abilify MyCite, used to treat schizophrenia, acute bipolar disorder and adult depression, is the first approved drug that can track medication ingestion and alert a patient’s physician or caregiver when it is taken.
5. Sutent may now be used to treat patients who’ve had a kidney surgically removed to lower the risk of cancer recurrence.
More articles on supply chain:
Geisinger, Intermountain among 11 healthcare groups urging CMS to add device identifiers to claims form
Genentech earns FDA approval for hemophilia drug
6 must-reads for supply chain leaders this week
